Patients with cancer are experiencing long-term survival following chemotherapy, but the treatment may also be associated with short and long-term toxicity, including the possibility of cognitive dysfunction. A literature overview indicated a significant association between chemotherapy and cognitive impairment but prospective longitudinal research is warranted to examine the degree and persisting nature of this decline. Although chemotherapeutic agents are unlikely to cross the blood-brain barrier, it has been alleged that the occurrence of neurotoxicity is linked to the pro-inflammatory cytokine pathways. Moreover in most cases many other factors could play an ancillary and concomitant role. The contribution of hormone therapy as well as emotional, social, behavioural and genetic factors should always be considered. Especially physical activity and cognitive training appear promising in the management of cognitive impairment but additional studies are required to establish their efficacy.

Cognitive impairment and chemotherapy: a brief overview / M. Vitali, C.I. Ripamonti, F. Roila, C. Proto, D. Signorelli, M. Imbimbo, G. Corrao, A. Brissa, G. Rosaria, F. de Braud, M.C. Garassino, G. Lo Russo. - In: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. - ISSN 1040-8428. - 118(2017 Oct), pp. 7-14. [10.1016/j.critrevonc.2017.08.001]

Cognitive impairment and chemotherapy: a brief overview

M. Imbimbo;G. Corrao;F. de Braud;
2017

Abstract

Patients with cancer are experiencing long-term survival following chemotherapy, but the treatment may also be associated with short and long-term toxicity, including the possibility of cognitive dysfunction. A literature overview indicated a significant association between chemotherapy and cognitive impairment but prospective longitudinal research is warranted to examine the degree and persisting nature of this decline. Although chemotherapeutic agents are unlikely to cross the blood-brain barrier, it has been alleged that the occurrence of neurotoxicity is linked to the pro-inflammatory cytokine pathways. Moreover in most cases many other factors could play an ancillary and concomitant role. The contribution of hormone therapy as well as emotional, social, behavioural and genetic factors should always be considered. Especially physical activity and cognitive training appear promising in the management of cognitive impairment but additional studies are required to establish their efficacy.
Cancer; Chemotherapy-related toxicity; Cognitive impairment; Antineoplastic Agents; Cognitive Dysfunction; Cytokines; Humans; Neoplasms; Prospective Studies; Hematology; Oncology; Geriatrics and Gerontology
Settore MED/06 - Oncologia Medica
ott-2017
Article (author)
File in questo prodotto:
File Dimensione Formato  
Critrevonc2017.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 920.68 kB
Formato Adobe PDF
920.68 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/551928
Citazioni
  • ???jsp.display-item.citation.pmc??? 19
  • Scopus 55
  • ???jsp.display-item.citation.isi??? 48
social impact